Error loading player: No playable sources found

3575

Non-Invasive Assessment and Disparities in Liver Disease

Date
May 19, 2024

SOCIETY: AGA This session deals with non-invasive assessment, biomarkers, and disparities in liver disease.

Moderators

Speaker Image for Kymberly Watt
Mayo Clinic
Speaker Image for Amon Asgharpour
Virginia Commonwealth University Health System

Related Products

Thumbnail for Microbiome & Microbial Therapy (MMT) Section Distinguished Abstract Plenary
Microbiome & Microbial Therapy (MMT) Section Distinguished Abstract Plenary
SOCIETY: AGA This session will feature a selection of the best abstracts submitted to the micobiome and microbial therapy section which encompass DGBI, IBD, cancer and liver disease…
Thumbnail for Portal Hypertension: Advances in Management of Disease
Portal Hypertension: Advances in Management of Disease
SOCIETY: AGA Updates and newer management strategies for portal hypertension in patients with liver disease…
Thumbnail for Clinical Advances in Steatotis Liver Disease and MASH
Clinical Advances in Steatotis Liver Disease and MASH
SOCIETY: AGA Newer and novel tools in understanding and management of patients with MASLD
Thumbnail for Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
DEVELOPMENT AND VALIDATION OF THE HOPE-EVL SCORE: A SCORING SYSTEM FOR IN-HOSPITAL MORTALITY FOLLOWING BAND LIGATION IN ESOPHAGEAL VARICEAL BLEEDING